Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.51 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.51 |
| ▸ | CASP3 | P42574 | 2/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | CASP4 | P49662 | 1/20 | 0.48 |
| ▸ | CASP7 | P55210 | 1/20 | 0.48 |
| ▸ | CASP9 | P55211 | 1/20 | 0.48 |
| ▸ | CASP6 | P55212 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TDP2 | O95551 | 1/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.41 |
| ▸ | CAPN9 | O14815 | 1/20 | 0.40 |
| ▸ | PTPRC | P08575 | 1/20 | 0.40 |
| ▸ | S100A4 | P26447 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.39 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1679791 | 0.86 | CASP3 (0.50) | NR1H2NR1H3CASP3CASP1CASP4 | |
| SCHEMBL5474246 | 0.76 | CASP3 (0.54) | NR1H2NR1H3CASP3CASP1CASP4 | |
| SCHEMBL12733648 | 0.74 | CASP3 (0.42) | NR1H2NR1H3CASP3ALDH1A1 | |
| SCHEMBL1953078 | 0.74 | CASP3 (0.54) | NR1H2NR1H3CASP3CASP1CASP4 | |
| SCHEMBL8364014 | 0.73 | NR1H2 (0.63) | NR1H2NR1H3CASP3CASP1CASP4 | |
| SCHEMBL516995 | 0.72 | CASP1 (0.63) | NR1H2NR1H3CASP3CASP1CASP4 | |
| SCHEMBL29945629 | 0.72 | CASP1 (0.63) | NR1H2NR1H3CASP3CASP1CASP4 | |
| SCHEMBL2488932 | 0.70 | LMNA (0.54) | NR1H2NR1H3CASP3CASP1CASP4 | |
| SCHEMBL17434341 | 0.69 | CYP3A4 (0.54) | CASP3CYP3A4TDP1ALDH1A1TDP2 | |
| SCHEMBL11641169 | 0.68 | CASP1 (0.36) | CASP3CASP1CASP4CASP7CASP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8507504-B2 | Process for producing bicycloaniline derivatives | MERCK SHARP & DOHME CORP. (US) | 2013-08-13 | — | — | US | disclosed |
| US-20110092520-A1 | PROCESS FOR PRODUCING BICYCLOANILINE DERIVATIVES | MERCK SHARP & DOHME LLC | 2011-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110092520-A1 | PROCESS FOR PRODUCING BICYCLOANILINE DERIVATIVES | WEE2, WEE1, DCK | NR1H2 4718/4885NR1H3 4458/4885CASP3 1603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.